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Abstract
Background: Tumor cells are characterized by accelerated growth usually accompanied by up-regulated pathways that
ultimately increase the rate of ATP production. These cells can suffer metabolic reprogramming, resulting in distinct
bioenergetic phenotypes, generally enhancing glycolysis channeled to lactate production. In the present work we showed
metabolic reprogramming by means of inhibitors of histone deacetylase (HDACis), sodium butyrate and trichostatin. This
treatment was able to shift energy metabolism by activating mitochondrial systems such as the respiratory chain and
oxidative phosphorylation that were largely repressed in the untreated controls.
Methodology/Principal Findings: Various cellular and biochemical parameters were evaluated in lung cancer H460 cells
treatedwiththe histone deacetylase inhibitors (HDACis), sodium butyrate(NaB) and trichostatinA (TSA).NaB and TSAreduced
glycolytic flux, assayed by lactate release by H460 cells in a concentration dependent manner. NaB inhibited the expression of
glucose transporter type 1 (GLUT 1), but substantially increased mitochondria bound hexokinase (HK) activity. NaB induced
increase in HK activity was associated to isoform HK I and was accompanied by 1.5 fold increase in HK I mRNA expression and
cognate protein biosynthesis. Lactate dehydrogenase (LDH) and pyruvate kinase (PYK) activities were unchanged by HDACis
suggesting that the increase in the HK activity was not coupled to glycolytic flux. High resolution respirometry of H460 cells
revealedNaB-dependentincreased ratesof oxygenconsumptioncoupledtoATPsynthesis. Metabolomic analysisshowed that
NaB altered the glycolytic metabolite profile of intact H460 cells. Concomitantly we detected an activation of the pentose
phosphate pathway (PPP). The high O2 consumption in NaB-treated cells was shown to be unrelated to mitochondrial
biogenesis since citrate synthase (CS) activity and the amount of mitochondrial DNA remained unchanged.
Conclusion: NaB and TSA induced an increase in mitochondrial function and oxidative metabolism in H460 lung tumor cells
concomitant with a less proliferative cellular phenotype.
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Introduction
The unchecked proliferation and invasion typical of cancer cells
are processes that can only be sustained when there is sufficient
energy supply, a feature that indicates the occurrence in
transformed cells of distinct phenotypes that necessarily involve
elements of the intermediary metabolism. In solid tumors it has
been shown by Otto Warburg that cells have adapted to rely on
anaerobic glycolysis as a strategy to maintain their prevailing
anabolic status [1]. However, the upregulation of glycolysis
exhibited by cancer cells does not necessarily imply a strict
anaerobic phenotype nor a dysfunctional oxidative phosphoryla-
tion system (OXPHOS). Rather, it is believed that the normal
interplay between the glycolysis in the cytosol and OXPHOS in
the mitochondria becomes disturbed or reprogrammed in tumor
cells. The Crabtree effect observed in cancer cells, or in rapidly
proliferating cells exemplifies the intimate connection between
glycolysis and the oxidative metabolism [2].
Interestingly, the anaerobic phenotype exhibited by cancer cells
may in fact represent the cause rather than the consequence of the
adaptive pressure. By considering that the glycolytic switch typical
of cancer cells is acquired at the very onset of carcinogenesis, the
idea arose that alterations in the glycolytic pathway may pre-
dispose cells to malignant transformation [3,4]. Selective advan-
tages for the transformed cells could result from various features.
For instance, it is known that hypoxia-inducible factor-1 (HIF-1a)
greatly stimulates the expression of glucose and monocarboxylate
transporters, glycolytic enzymes and induces a down regulation
in pyruvate dehydrogenase complex [5]. Moreover, tumor cells
present the isoform of HK that binds to the mitochondrial pore
forming protein voltage-dependent anion channel (VDAC). By
preventing the interaction of pro-apoptotic proteins with mito-
chondria the bound enzyme acts essentially as an anti-apoptotic
agent. Indeed, it has been shown that the release of apoptotic
proteins such as cytochrome c depends on the integrity of the N-
terminal portion of VDAC [6]. Since it was demonstrated that HK
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interaction with the VDAC 1 N-terminal region, the participation
of HK II as a promoter of cell differentiation was strengthened.
Enzymes of the glycolytic and oxidative pathways are, as
proteins in general, amenable to regulation of gene expression at
the level of chromatin. Chromatin structures alternate between
compacted and relaxed conformations which in turn depend on
acetylation and deacetylation of the histone protein core. The
enzymatic systems involved in these processes are histones acetyl
transferases (HATs) that add acetyl groups to lysine residues and
histone deacetylases (HDACs) that remove them. Compacted and
relaxed chromatins have been linked to gene expression repression
and activation, respectively. Although histones constitute the
prime substrates for HATs and HDCAs, other non-histone
proteins such as transcriptional factors-p53, pRb retinoblastoma
protein and HIF-1a; chaperones (HSP90), metabolic enzymes
(pyruvate kinase; acetyl-CoA synthase) and steroid receptors are
also acetylated/deacetylated by these enzymes. Therefore, HATs
and HDACs can affect a broad spectrum of biological processes
that include growth arrest, DNA repair, cellular bioenergetics, cell
death pathways (apoptosis, and autophagy), mitosis, generation of
reactive oxygen species (ROS), senescence and angiogenesis[7,8].
Because of its repressive actions, HDACs have become interesting
targets for the development of drugs that could retrieve the ability
of transformed cells to undergo apoptosis. Currently, several
HDAC inhibitors (HDACis) obtained from natural or synthetic
sources have been characterized. They are grouped into five
chemical classes which include hydroxamic acid and derived
compounds, benzamides, cyclic peptides, short chain fatty acids
and ketones.
As mentioned above, the HDACis change several functions in
normal and transformed cells which makes it difficult to pinpoint a
mechanism of action to these drugs. Several reports exist showing
the action of HDACi on the cell cycle and apoptosis. The present
work has dissected these broad actions by focusing on the energy
metabolism and demonstrating that HDACis can affect prolifer-
ation by acting on individual enzymes of the glycolytic and
oxidative pathways. The information available so far studying
mitochondria from rat liver treated with the short chain fatty acid
derivative valproate (VPA) have shown that it inhibits fatty acid b-
oxidation and in general depresses cell oxidative metabolism
leading to a decrease in both, the rate of O2 consumption coupled
to ATP synthesis and cytochrome oxidase activity [9,10,11].
Colorectal adenocarcinomas cells (HT29) treated with butyrate,
another short chain fatty acid class HDACi, inhibited glucose
uptake and oxidation, as well as ribose synthesis and increased de
novo fatty acid synthesis along with activation of the PPP. However
MIA cells, butyrate-resistant pancreatic adenocarcinoma, did not
display any changes in their metabolic profile after treatment.
These metabolic changes were correlated to induction of dif-
ferentiation processes mediated by butyrate and consequently with
its inhibitory effects on growth. Similar results were obtained with
cells exposed to TSA [12,13]. In myeloma cells, the HDACis VPA
and suberoylanilide hydroxamic acid (SAHA) induced a decrease
in glucose uptake, GLUT 1 expression and HK activity, leading to
apoptosis in tumor cells. In addition, these inhibitors increased the
amino acid catabolism [14].
The present study examined the roles of NaB and TSA on
several parameters, biochemical and morphological, of the H460
cell line of lung cancer cells in order to clarify how these HDACis
interferes with tumor cell homeostasis. The data showed con-
clusively that treatment with NaB for 24 h lead to a generally
enhanced oxidative metabolism clearly suggesting that HDACis
may transcend their canonical role at the chromatin level.
Methods
Cell Culture
H460, a human lung cancer cell (ATCC, deposited by AF
Gazdar, 1982), was maintained in RPMI 1640 medium supple-
mented with 10% fetal bovine serum (FBS), pH 7.4 at 37uCi na
humidified incubation chamber with 5% CO2. Cells were sub-
cultured every 2 days and used on experiments when they reached
85% confluence. The H460 cells were genotyped in our laboratory
using 8 loci plus amelogenin. All loci matched the ATCC DNA
STR profile.
Cell Viability and Citotoxicity Assay
For those assays the cells were grown on 24 and 96 well plates.
24 h after plating, cells were incubated with three different
concentrations of NaB (1, 3 and 10 mM) and TSA (0.02, 0.2 and
1 mM) for up to 48 h. After each treatment, cell viability was
accessed using MTT assay, as described previously [15], and
trypan blue dye exclusion assay. Citotoxicity was assayed by
lactate dehydrogenase (LDH) release after NaB treatment using
CytoTox96 Non-radioactive Cytotoxicity assay kit (Promega).
Cell Cycle Analysis
For DNA staining H460 cells were grown in 6 well plates and
treated with 3 or 10 mM NaB and 0.2 mM TSA for 24 h. The
cells were pelleted (1000 xgfor 5 min. at 4uC) and ressuspended in
500 uL of PI staining solution, composed of 50 ug/mL propidium
iodide (PI), 1 mg/mL RNAse and 0.2% Triton X-100. Samples
were incubated on ice for 15 min. in the dark and then analyzed in
FACSCalibur flow cytometer (Becton Dickinson) using CellQuest
software (Becton Dickinson), respectively, for data acquisition and
cell cycle distribution analysis.
Kinetics of Lactate Release in the Culture media
After treatment with different concentrations of NaB and TSA
for 24 h, the culture medium was replaced by fresh RPMI 1640
medium without phenol red and FBS. At the indicated times (0,
15, 30, 40, 50 and 60 min.), aliquots from culture medium were
collected to evaluate lactate release through this enzymatic assay:
lactate measurement was performed in a hydrazine/glycine buffer
(pH 9.2), containing 5 mg/mL b-NAD
+ and 15 units/mL lactate
dehydrogenase. The absorbance due to formation of NADH was
monitored in a microplate reader (SpectraMax M5, Molecular
Devices) at 340 nm and was correlated with the presence of lactate
on samples from a standard curve [16].
Preparation of Mitochondrial and Cytosolic Protein
Fractions
H460 cell pellet was mixed to a lysis buffer containing 10 mM
Tris-HCl pH 7.4, 0.25 M sucrose, 20 mM NaF, 1 mM DTT,
5 mM EDTA, 1 mM PMSF and protease inhibitors cocktail
(chymostatin, leupeptin, antipain, pepstatin A – Sigma-Aldrich).
The cell suspension was transferred to homogenizers (Wheaton
Potter-Elvehjem) for cell lysis. The suspension was centrifuged at
100 xgfor 5 min. at 4uC, the pellet with debris was discarded and
the resulting supernatant was centrifuged at 10000 xgfor 15 min.
at 4uC. Then the supernatant (cytosolic fraction) was used for
measurement of the recovered activities of HK, PYK, LDH and
glucose-6-phosphate dehydrogenase (G6PDH) and the pellet
(mitochondrial fraction) was used for measurement of the
recovered activities of mt-HK and CS. These extracts were used
for western blotting and enzymatic activity assays. Protein con-
centration was performed using the Bradford method.
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Enzymatic activities were measured using the following reaction
media: (a) for HK, 20 mM Tris-HCl pH 7.4, 10 mM MgCl2,
1m Mb-NAD
+, 1 unit/mL G6PDH (Leuconostoc mesenteroides), 0.1%
Triton X-100, 2 mM ATP and 5 mM glucose. (b) For PYK,
50 mM Tris-HCl pH 7.4, 5 mM MgCl2, 50 mM KCl, 0.2 mM b-
NADH, 2.5 mM ADP, 0.1% Triton X-100, 5 mM phosphoenol-
pyruvate, 0.5 units/mL lactate dehydrogenase. (c) For LDH,
50 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.2 mM b-NADH,
0.1% Triton X-100, 1 mM pyruvate. (d) For G6PDH, 50 mM
Tris-HCl pH 7.4, 5 mM MgCl2, 0.1% Triton X-100, 2 mM
glucose-6-phosphate and 0.2 mM b-NADH. The reactions were
started by the addition of 20–140 mg protein for HK and 10 mg
protein for PYK, LDH and G6PDH and were carried out at 37uC
for 5 min. After incubation, the samples were immediately boiled
and placed in ice. Absorbance was measured at 340 nm and the
value used to calculate the specific activity of the enzymes defined
as the amount of substrate formed per milligram of protein per
minute. (e) For CS, 50 mM Tris-HCl pH 8.1, 0.3 mM acetyl-
CoA, 0.1% Triton X-100, 0.1 mM DTNB, 0.5 mM oxaloacetate.
The reaction was started by the addition of 10 mg protein and
carried out at 30uC for 5 min. Absorbance was measured at
412 nm. (f) For succinate dehydrogenase (SDH), 50 mM phos-
phate buffer (pH 7.4), 0.1% Triton X-100, 0.8 mM KCN,
0.06 mM 2,6-dichlorophenolindophenol (DCIPIP), 1.1 mM phen-
azine (PMS) and 100 mg protein The reaction was carried out at
25uC for 7 min and was stopped with 10 mM malonate. The
reduction of DCPIP was monitored at 600 nm.
Western Blotting
25 mg of protein extracts were separated by standard SDS-PAGE
and transferred to nitrocelulose membranes by electroblotting in
buffer composed of 39 mM glycin, 48 mM Tris-base, 0.037% SDS
and 20% methanol. Western blotting was performed using primary
antibodies diluted in TBS, 0.1% Tween 20 and 5% BSA. Primary
antibodies against HK I, HKII and VDAC 2 (abcam) were used.
Oxygen Consumption of Intact and Digitonin-
Permeabilized H460 cells
O2 consumption rates were measured polarographically using
high-resolution respirometry (Oroboros Oxygraph-O2K). After the
treatment period, medium was removed and cells were either
suspended in RPMI (11.1 mM glucose and 2 mM glutamine) or
glucose free DMEM for measurements of O2 consumption of intact
cells, or in the respiration medium pH 7.0 (0.25 M mannitol,
10 mM MgCl2,1 0 m MK H 2PO4, 10 mM HEPES, 0.08 mM
EDTA, 1 mM EGTA and 0.1% fatty acid free BSA) for evaluation
of respiratory complexes of permeabilized cells. Routine consump-
tion, oligomycin-independent respiration (proton leak) and FCCP-
stimulated respiration (maximum respiration) were measured in
intact H460 cells as described previously [17]. NaB effects on
respiratory complexes of 0.003% digitonin-permeabilized H460
cells were performed following the addition of different substrates/
modulators such as 10 mM pyruvate + 10 mM malate (complex I-
linked substrates), 10 mM succinate (complex II-linked substrate),
0.5 mM rotenone, 100 mM ADP. When assaying state 3 induced by
2-deoxyglucose (2-DOG), 10 mM of 2-DOG was added. DatLab
software (Oroboros Instruments, Innsbruck, Austria) was used for
data acquisition and analysis.
RNA Extraction and cDNA Synthesis
Total RNA was isolated from H460 cells using TRIzol reagent
(Invitrogen) according to the manufacturer’s instructions. Total
RNA was quantified spectrophotometrically and 1 mg were treated
with 1 U of DNAse RNAse-free for 30 min. at 37uC. Reactions
were stopped by adding 1 mL of 20 mM EDTA and heating for
10 min. at 65uC. cDNA synthesis was performed using the DNAse
treated RNA according to High Capacity cDNA Reverse
Transcription Kit from Applied Biosystems.
Real Time PCR
Gene expression analysis was performed using 7500 Real Time
PCR (Applied Biosystems) and power SYBR-GREEN PCR
master MIX (Applied Biosystems). For this test primer pairs were
synthesized based on GenBank sequences of mRNA. The
sequences of the primers are presented in Table S1. The
comparative Ct method was used to compare changes in gene
expression levels [18]. Actin was used as an endogenous control.
Electron Microscopy
Cells were washed once in warm PBS and fixed in a solution
pH 7.2 containing 2.5% glutaraldehyde, 0.1 M sodium cacodylate
buffer, post- fixed with 1% OsO4 (osmium tetroxide) in 0.1 M
sodium cacodylate buffer. Afterwards, cells were washed with PBS,
dehydrated with acetone and embedded in Epon. Ultra-thin
sections (70 nm) were stained with uranyl acetate and lead citrate,
and observed in a Zeiss 900 electron microscope. For mitochon-
dria morphometry, twenty electron micrographs were taken from
each sample and analyzed for morphology. Measurements of each
mitochondrion profiles area in ultrathin sections were made using
Image J (NIH) software.
Nuclear Magnetic Ressonance (NMR) for Metabolomic
Analysis
Metabolomic screening of H460 cells was performed as
described in [19] with few modifications. Briefly, culture media
of non-treated and NaB-treated H460 cells were replaced by
glucose-free DMEM supplemented with D-[U-
13C] 5 mM glucose
and cells were incubated for 1 h. Following incubation, the
medium was removed and approximately 3610
7 cells were
suspended in glucose-free DMEM containing 10% deuterium
oxide. One-dimensional
13C spectra of intact H460 cells
metabolites were obtained at 25uC. Spectra of H460 cells
metabolites were acquired with a Brucker DRX 400 MHz using
a triple resonance probe (TXI). Spectra processing and analysis
were performed using Topspin 2.0 and metabolite assignment was
done by chemical shift comparison of known metabolites deposited
in the Human Metabolome Database v 1.0.
Statistical Analysis
Statistical analysis was performed using Graph Pad Prism 5.
The results were expressed as means 6 S.E.M for n independent
experiments. Statistical significance was determined by student’s t
test, one-way ANOVA and two-way ANOVA.
Results
Sodium butyrate and trichostatin A inhibited the
proliferation of H460 cells and induced morphological
changes compatible with a differentiation process
Initially, we performed assays to evaluate NaB and TSA effects
on cell viability to determine the best experimental conditions to
study HDACis effects on energy metabolism without interferences
caused by cytotoxicity. As observed by phase contrast microscopy,
H460 cells treated with NaB exhibited discrete differences in
comparison to control cells. The morphology observed was
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may have counteracted regulatory pathways that in tumor cells
would lead to dedifferentiation. The results in Figure 1 show
further that treatment with 10 mM NaB produced cells that were
less confluent and are slightly more elongated than the untreated
ones (Figure 1C and D). Interestingly, the morphology of H460
NaB treated cells resembled A549 cells, a more differentiated lung
cancer cell that does not show morphological changes upon NaB
treatment (Figure 1A and B). These alterations in cell shape were
possibly related to cytoskeleton reorganization, since treatment of
cells with NaB produced a marked redistribution of F-actin as
revealed by staining with rhodamine- labeled phaloidin (Figure S1;
Method S2). Based on this observation the question whether
10 mM NaB could have had cytotoxic effects on the cultures was
raised. Experiments involving simple cell count carried out at 24
and 48 h, showed a dose dependent effect on proliferation (Figure
S2A). At 24 h, treatment with 10 mM NaB induced a reduction of
50% over cells not exposed to the HDACi. At 48 h incubation the
number of live cells at 10 mM NaB was approximately 10%.
H460 cells incubated with NaB at concentrations of 1, 3 and
10 mM were then tested for viability using the MTT assay. The
results (Figure S2B) showed a moderate effect at 24 h yielding
almost 80% viability at 10 mM NaB and approximately 30%
viability after 48 h incubation with the same concentration.
Essentially, the same results were obtained when these experi-
ments were repeated with TSA, using concentrations spanning
0.02–1 mM, except that at the highest concentration, TSA seemed
to be more toxic than NaB (Figure S2D–E). These results showed
that NaB and TSA, although belonging to different chemical
classes, shared similar effects. Although the number of cells was
clearly reduced as a result of the NaB and TSA action, the main
effects of the two inhibitors could be best interpreted as inhibition
of proliferation, rather than a direct toxic effect. In order to test
whether the treated cells were damaged by the HDACis, lactate
dehydrogenase release was assayed after treatment for 24 and 48 h
with NaB and TSA (Figure S2F) at several concentrations. Lactate
dehydrogenase release was not significantly affected by NaB at
24 h (Figure S2C). At 48 h and only at a concentration of 10 mM
did NaB treatment significantly induced lactate dehydrogenase
release. Furthermore, inspection of treated cells by fluorescence
microscopy after staining with DAPI (Figure S1) revealed intact
nuclei and chromatin, a result which would argue against cell
damage. Because of the broad spectrum of activities of NaB,
experiments were conducted to check whether treatment of H460
cells with this inhibitor could influence cell distribution along the
major stages of the cell cycle. These experiments were carried
out by quantifying treated and untreated cells by means of
fluorescence activated cell sorting. The results in Figure S3A show
that following a 24 h treatment, most cells, approximately 80%,
were found at the G0/G1 phase of the cell cycle with a con-
comitant reduction of the S phase. Incubation of cells with 0.2 mM
TSA for 24 h produced a similar profile (Figure S3B). Taking into
account those results, the treatment of 10 mM NaB for 24 h
induced differentiation and inhibition of cell growth, but was not
toxic to H460 cells. Thus, experiments involving long term
incubation of cells with the HDACis were not extended beyond
24 h.
Sodium butyrate decreased lactate release of H460 cells,
reduced the expression of GLUT 1 and increased GLUT 3
expression
Regarding the energy metabolism, one of the main features of
highly proliferative cells, including tumor cells, is their shift to
anaerobic glycolysis [3,20,21]. The selective pressure, if applicable,
producing such an altered phenotype must result from regulatory
mechanisms that somehow are able to sense the energy status of
the cells. Therefore, as a first step towards uncovering metabolic
pathways affected by NaB and TSA, we inquired whether these
HDACis could directly affect the glycolytic flux of H460 cells. This
Figure 1. Sodium butyrate induces morphological changes and cell cycle arrest in H460 cells. The cells were incubated at 37uC
humidified incubator containing 5% CO2 and photographed under bright field using the documentation system of inverted microscope Nikon TS100.
(A) A549 cells non-treated. (B) A549 cells treated with 10 mM NaB for 24 h. (C) H460 cells. (D) H460 cells treated with 10 mM NaB for 24 h.
doi:10.1371/journal.pone.0022264.g001
H460 Lung Cancer Cell Metabolic Reprogramming
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22264series of experiments began by measuring the amount of lactate in
a culture medium after cell incubation with 3 and 10 mM NaB for
24 h. The amount of lactate released was then monitored at
regular intervals over a period of 60 min. The results are shown in
Figure 2A. The values observed in the lactate release were similar
to those observed by Pereira da Silva [19]. It can be seen that NaB
reduced lactate release in a dose dependent manner. A similar
pattern of inhibition of lactate release was obtained after
incubation of the cells with 0.2 mM TSA for 24 h (Figure S4A).
After 60 min. incubation, TSA-treated cells released approxi-
mately 60% of the amount of lactate released by controls. Lactate
fluctuations could occur as a consequence of disturbances in any
stage of the glycolytic pathway. Taking into consideration that in
the present work the experiments were carried out with cells in
culture, lactate recycling through gluconeogenesis was ruled out.
One possible fate for lactate could be the cells’ oxidative
metabolism, assuming of course that the mitochondria of the
tumor cells were functional. Therefore, lactate release was assayed
Figure 2. Sodium butyrate reduces lactate production and regulates glucose transporter isoform 1 (GLUT 1) and 3 (GLUT 3)
expression. After 24 h of treatment with 3 mM or 10 mM NaB, H460 cells were incubated with glucose-supplemented medium. Aliquots of
supernatants were collected every 10 minutes and incubated in hidrazine buffer pH 9.2, with an excess of NAD
+ and lactate dehydrogenase (LDH) for
measurement of lactate released. (A) Kinetics of lactate release and representation of lactate release after 60 minutes (inset). (B) After 30 minuteso f
incubation with glucose, 2 mg/ml antimycin A was added to the culture. Aliquots of the supernatant were taken at 10 minutes intervals and lactate
released was measured. The lactate production ratio of H460 cells in the presence and absence of antimycin A evidences the stimulation on lactate
production when oxidative phosphorylation was inhibited by the addition of this drug (indicated by the black arrow). Values represent mean 6 SEM;
N=4, *P,0.05. (C) Cells were treated with 3 mM or 10 mM NaB for 24 h and GLUT 1 and (D) GLUT 3 expression was determined by Real Time PCR.
Actin was used to normalize cDNA amounts. Values represent mean 6 SEM; N=3, *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0022264.g002
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addition of antimycin A. The results expressed as the ratio
between lactate release in the presence and absence of antimycin
A, are shown in Figure 2B. After 60 min. with NaB and antimycin
A, lactate release plateaued out exhibiting a twofold increase over
the untreated cells. 0.2 mM TSA produced a similar response to
antimycin A after 60 min. incubation (Figure S4B). Besides
showing that the oxidative metabolism is operational in H460
cells, and supposedly increased in HDACi treated cells, these
results also supported the interpretation that NaB and TSA did
indeed affect the glycolytic flux. However, glucose uptake by the
tumor cells could itself constitute the pacemaker for the entire
glycolytic pathway. Therefore, experiments were designed to test
whether NaB had any effect on the expression of GLUT 1 and
GLUT 3 using qRT-PCR. The results in Figure 2C shows that
NaB incubated at 3 and 10 mM during 24 h reduced the
expression of GLUT 1 (1.6 and 4, respectively) and increased
GLUT 3 expression (2.9X) in H460 cells.
Sodium butyrate increased mitochondria bound
hexokinase activity
The observed reduction in GLUT 1 and increased expression of
GLUT 3 (Fig 2C) suggested that a compensatory mechanism for
glucose uptake was operative in the cells. Thus, we asked whether
HK activity, an important element in the kinetics of glucose
uptake and glycolytic flux, could play a role. To investigate this,
the HK activity was performed and the expression of HK isoforms
was evaluated by qRT-PCR. Figure 3A shows that as a result of
incubation of H460 cells with 10 mM NaB for 24 h, the activity of
mitochondria bound HK increased twice as much as that of the
untreated controls. In contrast, NaB did not affect the activity of
cytosolic HK. The intracellular location of HK I was also
confirmed by immunofluorescence. The results are shown in
(Figure S5; Method S2). In these experiments, detection of
mitofusin (Mfn) I and II, proteins that are anchored to
mitochondria and participate in the maintenance of their
morphology and fusion, was carried out in the same preparation
so as to provide markers for the organelles. Comparison of the
Mfn plates (stained in red) to HK (stained in green), showed that
both proteins co-localized in the mitochondria. The higher
enzymatic activity observed in Figure 3A could have reflected an
increased expression of HK induced after a long term incubation
of cells with NaB. This possibility was investigated by assaying HK
I and HK II expression using qRT-PCR in H460 cells exposed to
3 and 10 mM NaB for 24 h. The results are shown in Figure 3B.
Both concentrations of NaB significantly increased the expression
of HK I. Conversely, NaB induced a decrease in the expression of
HK II. In the experiments measuring HK II expression
(Figure 3B), the values obtained after incubation of cells with 3
Figure 3. Treatment of H460 cells with sodium butyrate increases mitochondria bound hexokinase (mt-HK) activity and expression.
(A) Specific HK activity present in cytosolic and mitochondrial fractions of H460 cells treated or not with 10 mM NaB was assayed using an enzymatic
assay coupled to glucose 6-phosphate dehydrogenase. Values represent mean 6 SEM; N=4, *P,0.05. (B) Relative HK I and HK II expression was
determined by real time PCR. (C) Western-Blot using anti-HK I, HK II and VDAC primary antibodies. Values represent mean 6 SEM; N=3, *P,0.05;
**P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0022264.g003
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that NaB induced an increased expression of HK I was obtained
from experiments determining the actual amount of translated HK
by means of western blots. The results are shown in Figure 3C. It
can be seen that treatment of H460 cells with 10 mM NaB for
24 h clearly increased the intensity and the area of the band
corresponding to HK I associated to the mitochondria. However,
no alteration was observed in the amount of HKII. In contrast,
cytosolic HK I and II were barely detectable in controls and
treated cells. The higher amount of HK shown in Figure 3C could
not be explained by an increased availability of the mitochondrial
hexokinase acceptor, the VDAC, since the amounts of this protein
did not change significantly upon treatment with NaB. Whilst the
effect of NaB on the expression of HK isoforms was clearly
demonstrated, the inhibitor did not affect the activity of either
PYK or LDH. The results are shown in Table 1. The fact that
10 mM NaB did not affect these glycolytic enzymes strengthens
the idea that the HDACi is partially selective in its effect to
modulate the HK activity isoforms. Furthermore, the observation
that NaB did not significantly alter the activities of these glycolytic
enzymes suggested that the fluctuations leading to lactate
production shown in Figure 2A and 2B and Figure S4A and
S4B, were a consequence of disturbances at the earlier stages of
the glycolytic pathway, rather than at the end.
Sodium butyrate increased the activity of glucose 6-P-
dehydrogenase
The data showing a NaB induced overexpression of HK and its
consequent augmented activity had to contend with the observa-
tion that lactate release was diminished as a result of the HDACi
action on H460 cells. Because glucose-6-phosphate formed by HK
is also a substrate for G6PDH of the PPP. Moreover, Boren and co
workers have shown through metabolic control analysis that the
glucose-6-phosphate dehydrogenase is one of the main regulators
of the PPP [22]. We next inquired whether this sequence of
reactions could constitute an alternative sink for the phosphory-
lated sugar. Thus, G6PDH activity was assayed in H460 cells in
the presence and absence of NaB. The results are shown in
Figure 4. Incubation with 10 mM NaB did stimulate cytosolic
G6PDH activity by almost two fold. This result showed that NaB
induced a shunt of glucose-6-phosphate to PPP that can be
important to generation of the cell’s reductive power.
Sodium butyrate treatment increased mitochondrial
metabolism in H460 cells
The experiments in which antimycin A was used to evaluate
lactate release (Figure 2B and S4B) showed that cells treated with
NaB or TSA were more susceptible to oxidative phosphorylation
inhibition and, therefore, responded by increasing the glycolytic
flux and the amount of lactate released when compared to
controls. In view of the potential inclusion of mitochondria as
targets for NaB, the next experiments described the attempts to
directly measure respiratory parameters in the presence of the
HDACi. High-resolution respirometry allowed the detection of
small changes in O2 flux in the electron transport system coupled
or not to proton gradient and required lower numbers of cells.
Initially, O2 consumption rates were measured in intact H460 cells
treated or not with NaB for 24 h. The results are shown in
Figure 5A. A significant increase in routine respiration (in RPMI
medium containing 11.1 mM glucose) was observed with
approximately 42% enhancement induced by 10 mM NaB after
24 h incubation. The addition of oligomycin allowed the
evaluation of O2 consumption rate uncoupled to ATP synthesis
referred to as leak respiration. Although NaB did not promote any
effects on leak respiration, O2 consumption related to ATP
synthesis (i.e., coupled respiration=routine respiration – leak
respiration), was increased by 45% in treated cells (Figure 5B).
NaB treatment also promoted a significant increase in O2
consumption when mitochondria were at maximum respiratory
capacity, as indicated by the results of experiments in which the
proton ionophore carbonyl cyanide 4-(trifluoromethoxy) phenyl-
hydrazone (FCCP) was added, as shown in Figure 5B. A similar
pattern of increase in oxidative metabolism was obtained after
incubation of the H460 cells with 0.2 mM TSA for 24 h (Figure
S6). The effects of NaB on O2 consumption on H460 cells could
result from NaB catabolism itself. In order to address this point,
Table 1. Effect of sodium butyrate on recovered piruvate
kinase and lactate dehydrogenase activities from H460 cells.
Specific Activity (mmol x mg
21 xm i n
21)
(a)
Control NaB
Piruvate kinase 2.9160.23 2.3460.27
Lactate dehydrogenase 2.5960.17 2.8860.14
(a)Specific PYK and LDH activities present in cytosolic fraction of H460 cells was
assayed using an enzymatic assay coupled to lactate dehydrogenase. Values
represent mean 6 SEM; N=4 for PYK activity and N=6 for LDH activity.
doi:10.1371/journal.pone.0022264.t001
Figure 4. Treatment with sodium butyrate induces an increase
in specific glucose-6-phosphate dehydrogenase (G6PDH)
activity. H460 cells were treated with 10 mM NaB for 24 h and
specific G6PDH activity present in cytosolic fraction was assayed as
described under ‘‘Experimental Procedures’’. Values represent mean 6
SEM; N=5, *P,0.05.
doi:10.1371/journal.pone.0022264.g004
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consumption was measured in H460 cells grown without prior
addition of NaB for 30 min. No significant increments in O2
consumption were observed, under those conditions (data not
shown). As a result of the enhanced O2 consumption, parallel
experiments were conducted in order to show whether this pattern
was accompanied by an increase in ATP content of the treated
cells. The result in Table S2 (Method S1) showed that there was no
significant alteration in cellular ATP content upon treatment with
the HDACi. Although such a result would indicate that the
mitochondria are fully functional, the possibility that the ATP
detected originated in the glycolytic pathway or for that matter
from any other ATP producing reaction cannot be excluded.
Sodium butyrate abolished the Crabtree effect
Glutamine not only generates glutathione for the maintenance
of the cell’s reductive power, but also feeds anaplerotic pathways
providing intermediates of the TCA cycle such as glutamate and
a-ketoglutarate. In parallel, these reactions also produce NADPH.
Hence, experiments using high-resolution respirometry, were
carried out to test whether NaB could affect O2 consumption
by intact H460 cells in the presence of 11.1 mM glucose, or
glutamine alone. The results are shown in Figure 6. Untreated
H460 cells exhibited a significant increase in routine respiration
when glucose was removed from the medium, a response, known
as the Crabtree effect (Figure 6, open bars). Interestingly, in NaB
treated cells, this effect was not observed (Figure 6, black bars).
This result strengthens the hypothesis that the HDACis target the
glycolytic pathway and it might reflect yet another feature of the
differentiation process promoted by NaB. In parallel these results
also reinforced the notion that the mitochondria of H460 cells
appear to be fully functional and that NaB-treated cells displayed a
more oxidative phenotype.
Sodium butyrate treatment increased mitochondrial
respiration in complex II of permealized H460 cells and
succinate dehydrogenase activity
The effect of NaB to promote an increase in O2 consumption in
intact H460 cells could be better evaluated by directly analyzing
the redox activity of their electron transport system. For example,
complex I or II activities could be analyzed in digitonin-
permeabilized H460 cells treated or not with NaB using high
resolution respirometry. In this assay, one group of cells received
pyruvate/malate as substrates for complex I. Another group of
cells was treated with rotenone (complex I inhibitor) followed by
the addition of succinate as a substrate for succinate dehydroge-
nase (SDH) respiratory complex II. The results in Figure 7 show
that whereas there was no NaB associated effect on cells that
received pyruvate/malate, the HDACi increased O2 consumption
when succinate was used as respiratory substrate, suggesting a
Figure 5. High-resolution respirometry shows an increase in oxidative metabolism subsequent to treatment with sodium butyrate.
(A) Representative record of oxygen concentration and flow of intact H460 cells treated or not with 10 mM NaB for 24 h. During the assay, cells were
maintained in RPMI medium with glucose and without FBS. Black dashed line represents oxygen concentration in control cells and gray dashed line in
NaB treated ones. Black solid line represents oxygen flow in control cells and gray solid line in NaB treated ones. ‘‘O’’ 1 mg/mL oligomycin; ‘‘arrows’’
indicate the titration of FCCP (nM). (B) Effect of NaB treatment on respiratory parameters of intact H460 cells. Routine respiration - basal respiration of
H460 intact cells; Leak respiration - rate of oxygen consumption after the addition of oligomycin, that is, respiration not coupled to ATP synthesis;
FCCP - maximum respiratory capacity (induced by the addition of FCCP); Coupled respiration - respiration coupled to ATP synthesis, obtained by
subtraction of Leak from Routine respiration. Values represent mean 6 SEM; N=9, **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0022264.g005
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SDH. The analysis of SDH activity confirmed this increase in
mitochondrial complex II (Figure 7E). It has been shown
elsewhere that SDH activity prevented the pseudo-hypoxia that
leads to HIF stabilization and its downstream adaptative responses
[23,24] commonly observed in several types of cancer. Such result
indicated that SDH may have acted as a tumor suppressor
(Figure 7B and C).
Collectively the results shown here (Figures 3A, 5A and B)
suggested that the increase in mitochondrial respiration and mt-
HK I activity could be coupled as was demonstrated in brain
tissues which normally displays a high energy demand [25].
However, no mechanistic link between those two systems has been
established in lung cancer cells. The experiments that were
designed to fill this gap involved the incubation of cells with
10 mM NaB for 24 h followed by the direct measurements of O2
consumption in permeabilized H460 cells in the presence of the
glucose analogue 2-deoxyglucose (2-DOG). 2-DOG was used
because its phosphorylated form 2-DOG-6P it is not a strong
inhibitor of mt-HK catalyzed reaction as occurs with Glc-6P. Thus
2-DOG mimics a steady state physiological glucose phosphoryla-
tion in cells [25,26]. The results are shown in Figure 7D. In both
experiments with complex I or II linked substrates, NaB promoted
higher O2 consumption than in the untreated control cells. A
plausible explanation for these findings invokes the previous results
showing that NaB stimulates HK I expression and HK activities
(Figure 3A–C). Because HK I is able to phosphorylate 2-DOG,
this in turn could supply the ADP necessary to boost the oxidative
phosphorylation occurring within the mitochondria as shown in
Figure 7D.
NaB did not induce mitochondria biogenesis
Considering that an increase in cell oxidative metabolism
usually correlates with an increase in the number of mitochondria
in the cell we decided to investigate if NaB treatment induced
mitochondrial biogenesis. Mitochondrial biogenesis was investi-
gated using two different approaches: quantifying mitochondrial
DNA in relation to nuclear DNA as well as by assaying CS
activity. The results presented in Table 2 show that the copy
number of mitochondria DNA of control cells did not differ
significantly from that of NaB treated cells. A similar result was
obtained with CS activity. These results suggested that the
treatment with 10 mM NaB during 24 h did not induce
mitochondria biogenesis. In spite of these results, NaB was shown
to have an effect on the expression of Mfn, also shown in Table 2.
There was a significant increase in the expression of this protein,
indicating that rather than affecting mitochondrial biogenesis, the
higher amount of Mfn detected here may be involved with
tethering between functionally distinct organelles, such as the
endoplasmic reticulum [27] as well as mitochondria themselves.
Attempts to verify this possibility involved the examination by
electron microscopy of mitochondria obtained from cells treated
with 10 mM NaB. The results are shown in Figure 8. Analysis of
the plates did not allow any conclusion regarding the occurrence
of a higher frequency of bridging between mitochondria (m) and
ER (Figure 8, arrowhead), or for that matter any other recog-
nizable cellular structure. However, the most obvious alteration
induced by NaB was the presence of mitochondria that were more
elongated with a higher resolution of the cristae (Figure 8) in
comparison with controls. The increased expression of Mfn and
the appearance of more elongated mitochondria in the H460 cells
after treatment, suggest that NaB could induce a mitochondrial
fusion.
Sodium butyrate altered the glycolytic metabolite profile
of intact H460 cells
In order to evaluate whether the changes in mitochondrial
respiration and glucose oxidation were somehow involved in other
adaptive pathways of energy metabolism,
13C–NMR analysis of
the cells treated or not with NaB was carried out with intact cells.
The analysis of spectra shown in Figure 9 and Table 3 revealed
that NaB treatment promoted several changes on H460 cells
metabolic intermediates, a pattern suggestive of a significant
metabolic reprogramming. The largest differences were observed
in spectral region from 70 to 105 p.p.m. The contents of coenzyme
A (13) and 2-acetolactate (14) (involved in coenzyme biosynthesis
and pantothenate metabolism) were practically absent in NaB
treated-cells, indicating an under structuring process leading to
increased oxidative metabolism and confirming the respirometric
analysis experiments. Additionally, NaB treatment promoted a
severe decrease in the content of metabolites involved in pirymi-
dine metabolism, including uridine (10), deoxyinosine (11), deoxy-
guanosine (12), dGDP (15), dGTP (16), cytidine triphosphate (25)
and cytidine monophosphate (26), in agreement with cell cycle
arrest shown in Figure S3A. On the other hand, the contents of
5-methyl deoxycitidine (9) and 5-methylcytidine (8) (spectral region
102 to 103 p.p.m.) were greatly elevated in cells treated with NaB,
a result compatible with an anabolic status. Surprisingly, the
Figure 6. The crabtree effect is not observed in H460 cells after
sodium butyrate treatment. After treatment with 10 mM NaB for
24 h, H460 cells oxygen flow was measured on DMEM medium with or
without glucose containing 2 mM glutamine as respiratory substrate.
This result confirms the stronger oxidative metabolic profile of H460
cells treated with NaB. Values represent mean 6 SEM; N=5, **P,0.01;
***P,0.001.
doi:10.1371/journal.pone.0022264.g006
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cells. Since the synthesis of several metabolites depends on
nicotinamide metabolism, it is plausible that NaB treatment could
influence a wide range of anabolic or catabolic pathways.
Inspection of the
13C chemical shift from 70 to 80 p.p.m.,
showed that NaB treatment promoted a decrease in glycolytic
intermediates glucose-6-phosphate, fructose-6-phosphate, 1,3-bi-
phosphoglycerate (1,3BPG), 2-phosphoglycerate (2-PG). In agree-
ment with the previous (Figure 2A and B) results, the intracellular
lactate content in NaB treated cells, was also decreased as shown
by the NMR spectra. The decrease in GLUT1 and increase in
GLUT3 transcripts in H460 treated-cells shown in Figure 2C
Figure 7. Sodium butyrate treatment increases oxygen consumption when succinate is used as respiratory substrate. H460 cells were
treated with NaB for 24 h, permeabilized with 0.003% digitonin ‘‘D’’ and oxygen flow or concentration were measured using high-resolution
respirometry on respiration buffer. The substrates and/or modulators were added in the following order: 10 mM pyruvate + malate ‘‘P/M’’, 100 mM
ADP, 100 mM ADP, 10 mM 2-deoxy-D-glucose ‘‘2-DOG’’ and 200 mM FCCP ‘‘F’’ or 1 mM rotenone ‘‘R’’, 10 mM succinate ‘‘S’’, 100 mM ADP, 100 mM ADP,
10 mM 2-deoxy-D-glucose ‘‘2-DOG’’ and 200 mM FCCP ‘‘F’’. (A) and (B) Representative assays of oxygen concentration (gray dashed line) and oxygen
flow (black solid line) of permeabilized H460 cells. (C) Rate of O2 flow per cell after addition of the different substrates and/or modulators. Values
represent mean 6 SEM (N=7 – Control; N=10–10 mM NaB). **P,0.01; ***P,0.0001. (D) Hexokinase bound mitochondria activity stimulates oxygen
consumption in NaB treated H460 cells. The stimulus of oxygen consumption was measured as the difference between O2 flow per cell in presence of
glucose analogue 2-deoxy-D-glucose (2-DOG) and in the absence of ATP synthesis (state 4), in a high-resolution oxygraph. Values were expressed as
mean 6 SEM. N=7, * P,0.05; **P,0.01. (E) Specific SDH activity present in mitochondrial fraction of H460 cells treated or not with 10 mM NaB was
assayed using an enzymatic assay based on the PMS-mediated reduction of DCPIP. Values were expressed as mean 6 SEM. N=6, * P,0.05.
doi:10.1371/journal.pone.0022264.g007
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requirements of the cells subjected to sodium butyrate treatment.
The level of a metabolic intermediate is a result of the balance
between its rate of synthesis and consumption by the downstream
step. Thus, a decrease in a metabolite, for example, can be result
of an inhibition in its upstream formation step or an increase in its
downstream degradation step. Therefore, this decrease in several
glycolytic intermediates suggests a decreased flux through the
glycolytic pathway because lactate release and production is low
(Figures 2 and 9). The reduction in glucose-6-phosphate and
fructose-6-phosphate contents could be explained by the signifi-
cant increase in glucose-6-phosphate dehydrogenase activity
(Figure 4), which would channel glucose carbons to the PPP.
Since the committed step in PPP is the reaction catalyzed by
G6PDH, it can be assumed that the flux through the oxidative
branch of this pathway is increased. This idea was corroborated by
the decrease in NADP content, a metabolite which functions as a
co-substrate of G6PDH. Figure 9 and Table 3 also show
alterations in PPP intermediates due to NaB treatment. Contents
of 6-phosphogluconolactone, 6-phosphogluconate, ribulose-5-
phosphate, xylulose-5-phosphate and erytrose-4-phosphate were
decreased and of sedoheptulose-7-phosphate increased. Addition-
ally, an increase in phosphoribosyl pyrophosphate (PRPP) content
upon treatment was observed. The decrease in 6-phosphogluco-
nolactone, 6-phosphogluconate, ribulose-5-phosphate and xylu-
lose-5-phosphate agrees with the idea of an increased carbon flux
through PPP oxidative branch. The increase in sedoheptulose-7-
phosphate might indicate alterations in the equilibrium of
transaldolase and transketolase reactions, favoring sedoheptulose-
7-phosphate accumulation. This is also compatible with the
decrease in fructose-6-phosphate and erythrose-4-phosphate.
Lastly, the increase in PRPP content could be explained by the
suppression of purine and pyrimidine metabolism in NaB-treated
cells, this result is in agreement with the reduction in S phase of
cell cycle (Figure S3A).
A shift towards an oxidative phenotype induced by NaB
treatment was also supported by the decrease in the contents
of some L-aminoacids (leucine, asparagine, glutamate, lysine,
cysteine, alanine;
13C chemical shift 179 to 176 p.p.m. and 63 to
53 p.p.m. and 29 to 19) and some tricarboxilic acid inter-
mediates (oxoglutaric acid, citric acid, fumaric acid and malic acid)
and related intermediate (acetoacetic acid).
Discussion
Whether sporadic or hereditary, most if not all types of cancer
ultimately derive from single cells that have undergone irreversible
biochemical reprogramming. The phenotypes acquired by the
clones of transformed cells are such that the intrinsic pathways
normally acting as safeguards for the tissue and the organism
become subverted and/or abrogated. The phenotype that confers
virtually limitless replication to the transformed cells is costly in
terms of energy. In rapidly growing tumors, the prevalent
anabolism must be accompanied by upregulated pathways that
ultimately increase the rate of ATP synthesis for all processes
connected to growth and invasiveness and hence necessarily
involve elements of the intermediary metabolism. To make
matters even more complex, it is known that the metabolic
reprogramming exhibited by transformed cells is not homoge-
neously distributed throughout the tumor. Cells located at the
centre of the tumor mass are under more severe anoxic conditions
than those at the periphery and consequently two or more
populations are formed that can be loosely classified as aerobic
and anaerobic tumor cells depending on their location in this O2
gradient. Within a tumor, the mixed cell population of hypoxic
and normoxic cells exchange metabolites between each other
establishing a network of complementary pathways that collec-
tively have been termed biochemical symbiosis [28]. In this
situation it can be inferred that mitochondria of at least part of the
cell population are functional. In the present paper we confirmed
that aerobic glycolysis and oxidative metabolism coexist in tumor
Table 2. Effect of sodium butyrate on mt-DNA content,
citrate synthase activity and mitofusin I relative expression.
Control NaB
mt-DNA
(a) 1.00 1.2860.13
Citrate synthase
(b) 0.6860.15 0.8060.15
Mitofusin I
(c) 1.00 1.4060.1*
(a)Mitochondrial DNA quantification (mt-DNA/nDNA). Total DNA (cytosolic and
mitochondrial) was extracted from control and NaB treated cells and NADH-
dehydrogenase subunit I (a gene coded by the mitochondrial genome)
content was estimated by real-time PCR analysis. Actin DNA (a nuclear coded
gene) was used to normalize DNA amounts. Values represent mean 6 SEM;
N=4.
(b)Specific citrate synthase activity (mmol x mg
21 xm i n
21) present in
mitochondrial fraction of H460 cells treated with 10 mM NaB for 24 h. Values
represent mean 6 SEM; N=5.
(c)Mitofusin I mRNA relative expression. Actin was used to normalize cDNA
amounts. Values represent mean 6 SEM; N=3, *P,0.05.
doi:10.1371/journal.pone.0022264.t002
Figure 8. Sodium butyrate treatment alters mitochondria structure in H460 cells. Electron microscopy of longitudinal sections of (A) H460
cells control and (B) treated with 10 mM NaB for 24 h. Bars: 1 mm. Arrowheads show the proximity between endoplasmic reticulum and
mitochondria.
doi:10.1371/journal.pone.0022264.g008
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PLoS ONE | www.plosone.org 11 July 2011 | Volume 6 | Issue 7 | e22264Figure 9. Metabolomics profile by NMR spectroscopy. (A) Control H460 cells or (B) cells treated for 24 h with 10 mM NaB were incubated in
DMEM containing
13C-glucose. After the incubation, cells were harvested, and intact cells were analyzed by NMR spectroscopy. Spectra highlight the
enrichment of the following
13C-containing informative metabolic intermediates: (1) Oxoglutaric acid; (2) Citric acid; (3) Fumaric acid; (4) L-
Asparagine; (5) L-Glutamic acid; (6) L-Lysine; (7) L-Leucine; (8) 5-Methylcytidine; (9) 5-Methyldeoxycytidine; (10) Uridine; (11) Deoxyinosine; (12)
Deoxyguanosine; (13) Coenzyme A; (14) 2-Acetolactate; (15) dGDP; (16) dGTP; (17) NAD; (18) NADPH; (19) NADP; (20) Phosphoribosyl pyrophosphate
(PRPP); (21) Sedoheptulose 7-phosphate; (22) Xylulose 5-phosphate; (23) Fructose 6-phosphate; (24) Gluconolactone; (25) Cytidine triphosphate; (26)
Cytidine monophosphate; (27) 2-Phospho-glyceric acid; (28) Glucose 6-phosphate; (29) 6-Phosphonoglucono-lactone; (30) Glyceric acid 1,3-
biphosphate, (31) Malic acid; (32) 6-Phosphogluconic acid; (33) Erythrose 4-phosphate; (34) Ribulose 5-phosphate; (35) Acetoacetic acid; (36) L-
Glutamine; (37) L-Cysteine; (38) L-lactate; (39) L-Alanine.
doi:10.1371/journal.pone.0022264.g009
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interactions and that NaB and TSA seem to disturb this energetic
equilibrium. We show for the first time that these HDACis reduce
the glycolytic metabolism and increase O2 consumption coupled to
ATP synthesis in H460 cells. In this scenario, the HDACis action
transcend their role at the chromatin level because non-histone
proteins can be acetylated and most intermediate metabolic
enzymes are acetylated, including enzymes of glycolysis, fatty acid
metabolism and Krebs cycle [29].
Initially, whatever metabolic reprogramming occurred upon
treatment of the cells with NaB, no gross morphological changes
were observed at the level of light and electron microscopy.
Likewise, the nuclear structure of treated cells was preserved,
which makes it improbable that NaB had any disruptive effects on
cell architecture, including intracellular compartmentation. In
agreement with this view, it is worth mentioning that any known
direct interaction of NaB with the cells seems to be receptor
mediated, involving, for example solute transporters such as
monocarboxylate transporter SMCT1 (SLC5A8) [30,31]. Inci-
dentally, it has been reported that SMCT1 is usually silenced in
cancer cells, a fact that may explain why relatively high
concentrations of butyrate had to be used in the present work
and in the literature [32]. Indeed, TSA which is readily absorbed
by the cells [33] exerted its inhibitory effects at much lower
concentrations than NaB. Other issues relating to solute transport
through the membranes of H460 cells may have a direct bearing
on the results involving lactate efflux. We showed that H460 cells
treated with NaB and TSA displayed a diminished lactate release
(Figure 2A and S4A), a result which could have reflected a direct
inhibitory effect of the HDACi on any of the enzymes
participating directly or indirectly in glycolysis. This excluded
lactate dehydrogenase, which was shown here to be unaffected by
the NaB. In order to maintain a high rate of glycolysis, it is
mandatory for the tumor cells to have access to a ready supply of
glucose. In many types of cancers, glucose transport is performed
by class 1, 3 and 4, which as a rule can be overexpressed in tumor
cells. It has been suggested that GLUT 1 and GLUT 3 are
regulated by activation of HIF-1a [5,34]. In the present work we
showed that NaB treatment, particularly at 10 mM, strongly
inhibited the expression of GLUT 1 and increased GLUT 3
expression (Figure 2C) in H460 cells, a result which suggest that a
compensatory mechanism for glucose uptake is taking place.
GLUT 1 is present in a variety of tissues that sense and respond to
fluctuations in blood glucose levels. Our results (Figures 2 and 3)
indicated that HDACi effects on GLUT and HK in H460 is
similar to that of brain cells. In this context, Gould and Holfman
suggested that under normal conditions the capacity of HK to
phosphorylates glucose (the main energy source) is considerably
greater than the capacity of the glucose transport systems in brain
cells. However, under conditions of either high glucose demand or
hypoglycemia, the expression of GLUT 3 in the brain with a low
Km for hexoses may be required as an ancillary transport system
[35].
Upon entering the cell after the GLUT 1 barrier, glucose is
immediately phosphorylated and thus initiates the glycolytic
pathway. In H460 cells, HK associated to the mitochondria was
found to be overexpressed as a consequence of NaB treatment
(Figure 3A). The question remained as to which HK isoform
responded to the HDACi. This question was addressed by real
time PCR which revealed that isoform HK I was upregulated and
HK II down regulated by NaB (Figure 3B). Upregulation of HK I
was rather surprising and raised some points for speculation. For
example, how did this finding fit with the general NaB induced
depression of glycolysis reflected by the diminished lactate efflux?
This question could be answered, at least partially, by highlighting
the results in Figure 4 that show clearly that NaB was able to
stimulate the activity of G6PDH indicating that G6P produced by
HK I could be diverted to the PPP. The fate of G6P as a substrate
to G6PDH also explains why G6P did not feedback inhibit HK I
activity. In addition, activation of the PPP would provide a salvage
pathway for anabolic metabolites in parallel with NADPH
formation as a co adjuvant for reductive synthesis.
Admittedly, other enzymes of the glycolytic pathway that were
not investigated in the present work might have played key roles in
the overall effects produced by the HDACis. One such example is
hexose phosphate isomerase (HPI) which has been recently shown
to play an important modulatory activity in glycolysis using kinetic
models [36]. Because HPI can directly affect both, G6P and
fructose-6-phosphate (F6P) concentrations, and simultaneously be
subject to inhibition by fructose 1,6-bisphosphate and PPP
intermediaries, its response to HDACis could perhaps explain
some of the observations described here. These experiments are
currently under way.
If glutamine catabolism is representative of the status of
mitochondria of H460 cells, one could conclude that as a whole
the organelle seems to be fully functional. As a matter of fact, we
observed that NaB stimulated mitochondrial metabolism of H460
cells by measuring several parameters which collectively could be
summarized as an enhancement of O2 consumption associated to
ATP synthesis (Figure 5). For instance, a large increase in
Table 3. Effect of NaB on the metabolites content in H460 cells.
METABOLITES CONTENT
INCREASE DECREASE
Aminoacid and oxidative
metabolism
----- Coenzyme A (13), 2-acetolactate (14); NAD (17), NADPH (18), NADP
(19); leucine (7), asparagine (4), glutamate (5), lysine (6), cysteine (37),
alanine (39); oxoglutaric acid (1), citric acid (2), fumaric acid (3), malic
acid (31), acetoacetic acid (35);
Pyrimidine and purine
metabolism
5-methylcytidine (8), 5-methyl deoxycitidine (9); PRPP (20); Uridine (10), deoxyinosine (11), deoxyguanosine (12), dGDP (15), dGTP
(16), cytidine triphosphate (25), cytidine monophosphate (26);
Glycolysis ----- glucose-6-phosphate (28), fructose-6-phosphate (23), 1,3-
biphosphoglycerate (30), 2-phosphoglycerate (27), lactate (38);
Pentose Phosphate
Pathway
sedoheptulose-7-phosphate (21), PRPP (20); 6-phosphogluconolactone (29), 6-phosphogluconate (32), ribulose-5-
phosphate (34), xylulose-5-phosphate (22), erytrose-4-phosphate (33);
NADP (19);
doi:10.1371/journal.pone.0022264.t003
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was added (Figure 7D) support the idea that the increased routine
respiration in intact cells (Figure 5) is due to an increase in the HK
activity bound to mitochondria. In this pro-oxidant scenario, the
ADP produced by high HK activity could control both membrane
potential and ROS generation through an ADP-recycling
mechanism similar to that proposed by Da-Silva et al [25].
In connection with the mechanism of NaB activation of
respiration, various interpretations, not necessarily mutually
excluding, are possible. In one scenario, there could be a direct
interaction of the HDACi with any of the mitochondrial
components, similarly to what was described for HK. Conversely,
NaB could act elsewhere and ultimately affect the respiratory
parameters of the mitochondria. Perhaps the broadest consider-
ation that must be taken into account is the possibility that most if
not all the HDACis effects described in the present work could
have been brought about by an action on a central factor that, in
turn, would affect other pathways. One possibility is that HDACis
are decreasing HIF-1a, and this effect decreases glycolysis
maintained by HIF-1a. A key transcription factor that knowingly
acts as the hub for many processes associated to the cell cycle and
the energy metabolism itself. Thus, by preferentially targeting
HIF-1a, NaB or TSA could indirectly affect hundreds of other
genes. At any rate, investigation of the effect of HDACis on HIF-
1a regulation and on key actors of anaerobic and oxidative
metabolism is currently under way.
Although more evidence has yet to be procured, the set of
results contained herein suggests that NaB and TSA could induce
H460 cells to assume an altogether differentiated state. It is
proposed that in this differentiated phenotype, cells actually shift
towards more oxidative metabolism akin to untransformed cells.
Ultimately, the enhanced oxidative metabolism would harm the
H460 cells by way of excessive production of ROS that can cause
cell death. In this context, the H460 cells treated with NaB could
activate antioxidant defense mechanisms related to the increase in:
(a) HK activity bound to mitochondria (Figure 3A), which
increases ADP recycling; (b) G6PDH activity (Figure 4), which
increases PPP flux and NADPH supply; and (c) the expression of
Mfn 1 (Table 2), which, may reflect the initial stages of a process of
mitochondrial fusion that can ultimately act as inhibitor of
apoptosis. Indeed it has been shown that under oxidative stress
mitochondria can rescue their membrane potential [37]. Although
the notion that NaB and TSA induced generation of ROS is a
reasonable proposition, it must be mentioned that the topic of
ROS and cancer cells is in itself quite controversial. There are data
supporting the view that ROS are in fact essential requirements for
the survival of tumor cells [38,39], even though the mechanism
whereby ROS would support tumor growth remains elusive.
Taken together the results presented here revealed a unique
biochemical profile induced by NaB and TSA. The data
essentially showed that alterations in the glycolytic flux triggered
an enhancement of mitochondrial function that was not, however,
paralleled by cell proliferation. Whilst further studies are
paramount to unveil the mechanisms underlying the interplay
between glycolysis and oxidative metabolism, the groundwork
established in the present work already suggests that the
stimulation of the oxidative metabolism in tumor cells may be
an interesting strategy for chemotherapy.
Supporting Information
Figure S1 Sodium butyrate induces F-actin rearrange-
ments in H460 cells. H460 cells were gown in the absence (A)
or presence (B) of 10 mM NaB. Cells were labeled with
rhodamine-conjugated phaloidin (red) and DAPI (blue), to allow
visualization of actin citoeskeleton and nuclei, respectively.
Representative immunofluorescence images obtained using a
Zeiss AxioObserver Z1 are shown. Bars: 30 mm.
(TIF)
Figure S2 Sodium butyrate and trichostatin A induce
time and dose-dependent inhibition of growth in H460
cells. Cells were grown in the absence or presence of various
concentrations of NaB (1, 3 and 10 mM; A–C) or TSA (0.02, 0.2
and 1 mM; D–F) for 24 or 48 h. At indicated times, cell number
and viability were analyzed by trypan blue exclusion (A and D)
and MTT assay (B and E). Also, citotoxicity of the different
amounts of NaB or TSA was estimated by measurement of lactate
dehydrogenase (LDH) release using CytoTox96 Non-Radioactive
Cytotoxicity Assay Kit (Promega) (C and F). Values represent
mean 6 SEM; N=3, *P,0.05; **P,0.01; ***P,0.001.
(TIF)
Figure S3 Sodium butyrate and trichostatin A induces
cell cycle arrest and inhibits cellular DNA synthesis.
H460 cells were treated or not with 3 or 10 mM NaB (A) and
0.2 mM TSA (B) for 24 h. Posteriorly cells were harvested,
permeabilized, incubated with propidium iodide and had its
DNA content analyzed by flow cytometry using FACScan. Values
represent mean 6 SEM; N=4, *P,0.05; **P,0.01; ***P,0.001.
(TIF)
Figure S4 Trichostatin A reduces lactate production in
H460 cells. After 24 h of treatment with 0.2 mM TSA, H460
cells were incubated with glucose-supplemented medium. Aliquots
of supernatants were collected every 10 min. and incubated in
hidrazine buffer pH 9.2, with an excess of NAD
+ and lactate
dehydrogenase (LDH) for measurement of lactate release. (A)
Kinetics of lactate release and representation of lactate release
after 60 minutes (inset). (B) After 30 minutes of incubation with
glucose, 2 mg/ml antimycin A was added to the culture. Aliquots
of the supernatant were taken at 10 minutes intervals and lactate
released was measured. The lactate production ratio of H460 cells
in the presence and absence of antimycin A evidences the
stimulation on lactate production when oxidative phosphorylation
was inhibited by the addition of this drug (indicated by the black
arrow). Values represent mean 6 SEM; N=4, *P,0.05.
(TIF)
Figure S5 HK I is bound to mitochondria in H460 cells.
Control (A and C) or NaB treated (B and D) H460 cells were
labeled with antibodies against mitofusin I (A–B) or mitofusin II
(C–D) (red), Hexokinase I (green). Merge HK + Mfn (yellow) and
DAPI (Blue). Representative images taken with an inverted
fluorescence microscope Zeiss AxioObserver Z1 are shown. Bars:
30 mm.
(TIF)
Figure S6 High-resolution respirometry shows an in-
crease in oxidative metabolism subsequent to treatment
with trichostatin A. (A) Representative record of oxygen
concentration and flow of intact H460 cells treated or not with
0.2 mM TSA for 24 h. During the assay, cells were maintained in
RPMI medium with glucose and without FBS. Black dashed line
represents oxygen concentration in control cells and gray dashed
line in TSA treated ones. Black solid line represents oxygen flow in
control cells and gray solid line in TSA treated ones. ‘‘O’’ 1 mg/mL
oligomycin; ‘‘arrows’’ indicate the titration of FCCP (nM). (B) Effect
of TSA treatment on respiratory parameters of intact H460 cells.
Routine respiration - basal respiration of H460 intact cells; Leak
respiration - rate of oxygen consumption after the addition of
H460 Lung Cancer Cell Metabolic Reprogramming
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- maximum respiratory capacity (induced by the addition of FCCP);
Coupled respiration - respiration coupled to ATP synthesis,
obtained by subtraction of Leak from Routine respiration. During
the assay, cells were maintained in RPMI medium with glucose and
without FBS. Values represent mean 6 SEM; N=5, *P,0.05,
**P,0.01; ***P,0.001.
(TIF)
Table S1 List of primer sequences used for quantitative
Real Time PCR.
(DOC)
Table S2 Effect of sodium butyrate on ATP content in
H460 cells. ATP content was assayed using an enzymatic
method with hexokinase and glucose-6-phosphate dehydrogenase
[40]. Values represent mean 6 SEM; N=3.
(DOC)
Method S1 ATP Content.
(DOC)
Method S2 Immunocytochemistry.
(DOC)
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